Progress in Treating Advanced Melanoma: Pharmacists

Health-System Edition, January 2019, Volume 8, Issue 1

In the United States, about 13% of patients present with advanced melanoma (9% with regional disease and 4% with distant metastatic disease).

FACULTY:

LeAnn B. Norris, PharmD, FCCP, BCPS, BCOP, Clinical Associate Professor, University of South Carolina College of Pharmacy, Columbia, South Carolina

EDUCATIONAL OBJECTIVES:

At the completion of this activity, the participant will be able to:

  • Identify the treatment options for patients with advanced melanoma
  • Examine the latest clinical data for patients with advanced melanoma
  • Explain the role of the pharmacist in supporting optimal treatment strategies in advanced melanoma management

TARGET AUDIENCE: Pharmacists

ACTIVITY TYPE: Application

RELEASE DATE: December 28, 2018

EXPIRATION DATE: January 12, 2020

ESTIMATED TIME TO COMPLETE ACTIVITY: 2.0 hours

FEE: This lesson is offered for free at www.pharmacytimes.org.